Clinical Nutrition Market Size, Share & Trends Analysis Report By Product (Parenteral, Enteral, Oral), By Application (Malabsorption/GI Disorder/Diarrhea, Cancer Care), By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Clinical Nutrition Market Size, Share & Trends Analysis Report By Product (Parenteral, Enteral, Oral), By Application (Malabsorption/GI Disorder/Diarrhea, Cancer Care), By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030


Clinical Nutrition Market Growth & Trends

The global clinical nutrition market size is expected to reach USD 44.17 billion by 2030, growing at a CAGR of 5.34 %, according to a new report by Grand View Research, Inc. The rising geriatric population and prevalence of chronic diseases coupled with innovation in personalized and targeted solutions and advancement in healthcare infrastructure are some of the factors driving the growth of market.

According to the World Health Organization (WHO), the global population aged 60 years and older is expected to surge from approximately 1 billion in 2020 to about 1.4 billion in 2030, projected to nearly double to approximately 2.1 billion by 2050. Over recent years, there has been a significant rise in the number of older individuals diagnosed with critical health conditions. Furthermore, various studies published by the National Center for Biotechnology Information (NCBI) indicate that individuals aged 65 and above are at an elevated risk of developing chronic diseases, including Alzheimer's disease, Parkinson's disease, and other neurological disorders.

For example, the Alzheimer's Association reports that out of the 5.5 million Americans affected by Alzheimer's disease, an estimated 5.3 million are 65 years or older. Consequently, healthcare professionals are increasingly focusing on optimizing clinical nutrition interventions for older adults, thereby boosting the market growth. Moreover, the aging process compromises the immune system, heightening vulnerability to infectious diseases and impacting essential bodily functions. Myelodysplastic syndromes, characterized by reduced blood cell production leading to inadequate and/or immature red blood cells, elevate the risk of infection and complications related to anemia, consequently driving demand for enteral feeding formulas.

Rising incidence of targeted diseases and advancements in drug development are expected to drive the demand for disease-specific formulas. Clinical nutrition is extensively used for the personalized treatment of diseases, such as cystic fibrosis, cancer, and so on. Prominent companies such as Nestlé specialize in personalized clinical nutrition products, which include Deplin for depression and Metanx for diabetes. Deplin is different from nonprescription folic acid, as it contains already-activated folate. It is to be noted that 70% of the patients suffering from depression have a low ability to activate folate, and therefore, the demand for medical foods, such as Deplin, has increased for various nonmetabolizing patients. These factors are likely to drive the demand for clinical nutrition by helping enhance the effectiveness of the treatment and improving the overall quality of medical treatment

The COVID-19 pandemic has led to a rise in the burden on healthcare services and an increase in the treatment sensitivity of critically ill patients. Patients who tested positive for COVID-19 often experience weakened immunity and disruption in respiratory & other systems. For instance, as highlighted in a publication from Elsevier's Public Health Emergency Collection, nearly half of severely ill COVID-19 patients manifest gastrointestinal complications such as hypomotility. In addition, patients experienced various other abdominal problems, leading to an increase in the adoption of clinical nutrition at global and country levels.

Furthermore, numerous studies justified the utilization of parenteral nutrition for individuals experiencing malnutrition issues, which raised during the pandemic, thereby contributing to market expansion. For instance, as per an article published in the Journal of the Academy of Nutrition and Dietetics, patients admitted to the ICU for COVID-19 treatment suffered from acute malnourishment. This raised the usage of parenteral nutrition products increased in the market during the pandemic.

Various initiatives undertaken by key players in the market to strengthen its position is positively impacting the market growth. For instance, in March 2023, Danone acquired ProMedica, a Poland-based company that specializes in providing care services for patients in their homes. This acquisition is part of Danone's lucrative specialized nutrition market expansion strategy, to strengthen its presence in Poland.Similarly, in January 2023, Nestle announced an investment of USD 43 million to expand its manufacturing facility in Eau Claire, Wisconsin in the U.S.

Clinical Nutrition Market Report Highlights
  • Based on product, the oral nutrition segment held the largest revenue share of 53.3% in 2023. The rising prevalence of malnutrition among the adult population and the increase in the instances of obesity, rising chronic diseases such as cancer, diabetes are the major factors boosting the market growth.
  • The parenteral nutrition type segment is projected to grow at a fastest CAGR over a forecast period
  • Based on application, the cancer care segment dominated the market with a revenue share of 15.13% in 2023, whereas the malabsorption segment is projected to showcase substantial growth throughout the forecast period
  • Institutional sales channel played a pivotal role, dominating the sales channel segment with the largest market share of 45.8% in 2023. On the other hand, the online channels segment is anticipated to exhibit the fastest CAGR of 6.15% from 2024 to 2030
  • In 2023, North America held the largest revenue share of 32.62%, while Asia Pacific is expected to witness the fastest growth due to improving healthcare infrastructure, rising healthcare expenditure, high occurrence of preterm births, and growing per capita income
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Application Outlook
2.2.3. Sales Channel Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Clinical Nutrition Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Pricing Analysis Around the Medical Food Market
3.3. Industry Analysis
3.3.1. User Perspective Analysis
3.3.2. Key End Users
3.4. Technology Outlook
3.5. Regulatory Framework
3.6. Market Dynamics
3.6.1. Market Drivers Analysis
3.6.1.1. Rising geriatric population
3.6.1.2. Growing prevalence of chronic diseases
3.6.1.3. Increasing incidence of Cancer
3.6.1.4. Increasing risk of malnutrition
3.6.1.5. Shifting trend toward the consumption of disease-specific formulas
3.6.1.6. Growing demand for neonatal and preterm enteral feeding
3.6.1.7. Rising organizational strategic initiatives To enhance market presence
3.6.2. Market Restraints Analysis
3.6.2.1. Lack of awareness in the medical community
3.6.2.2. Shortage of parenteral nutrition products
3.6.2.3. Improper categorization of clinical nutrition
3.6.3. Industry Challenges and Opportunity Analysis
3.7. Clinical Nutrition Market Analysis Tools
3.7.1. Porter’s Analysis
3.7.1.1. Bargaining power of the suppliers
3.7.1.2. Bargaining power of the buyers
3.7.1.3. Threats of substitution
3.7.1.4. Threats from new entrants
3.7.1.5. Competitive rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political landscape
3.7.2.2. Economic and Social landscape
3.7.2.3. Technological landscape
3.7.2.4. Environmental landscape
3.7.2.5. Legal landscape
3.8. Major Deals & Strategic Alliances Analysis in the Clinical Nutrition Industry
3.9. Impact of COVID-19
Chapter 4. Clinical Nutrition Market: Product Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. Clinical Nutrition Market: By Product, 2018 to 2030
4.5. Oral Nutrition
4.5.1. Oral Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Enteral Feeding Formulas
4.6.1. Enteral Feeding Formulas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.1.1. Standard Formula
4.6.1.1.1. Standard Formula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.6.1.2. Disease Specific Formula
4.6.1.2.1. Disease Specific Formula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.7. Parenteral Nutrition
4.7.1. Parenteral Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.1.1. Carbohydrates
4.7.1.1.1. Carbohydrates Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.7.1.1.2. Parenteral Lipid Emulsion
4.7.1.1.3. Parenteral Lipid Emulsion Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.7.1.1.4. Single Dose Amino Acid Solution
4.7.1.1.5. Single Dose Amino Acid Solution Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.7.1.1.6. Trace Elements
4.7.1.1.7. Trace Elements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.7.1.1.8. Vitamins & Minerals
4.7.1.1.9. Vitamins & Minerals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Clinical Nutrition Market: Application Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. Clinical Nutrition Market: By Application, 2018 to 2030
5.5. Alzheimer’s Disease
5.5.1. Alzheimer’s Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Nutrition Deficiency
5.6.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Cancer Care
5.7.1. Cancer Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Diabetes
5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Chronic Kidney Disease
5.9.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Orphan Disease
5.10.1. Orphan Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Dysphagia
5.11.1. Dysphagia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.12. Pain Management
5.12.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.13. Malabsorption/GI Disorder/Diarrhea
5.13.1. Malabsorption/GI Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.14. Others
5.14.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Clinical Nutrition Market: Sales Channel Estimates& Trend Analysis
6.1. Definition and Scope
6.2. Sales Channel Market Share Analysis, 2023 & 2030
6.3. Segment Dashboard
6.4. Clinical Nutrition Market: By Sales Channel, 2018 to 2030
6.5. Online Sales Channel
6.5.1. Online Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Retail Sales Channel
6.6.1. Retail Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Institutional Sales Channel
6.7.1. Institutional Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Clinical Nutrition Market: Regional Estimates & Trend Analysis by Country, Product, Application, and Sales Channel
7.1. Definition and Scope
7.2. Regional Market Share Analysis, 2023 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. SWOT Analysis
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. Clinical Nutrition Market Share, By Region, 2023 & 2030 (USD Million)
7.7. North America
7.7.1. North America Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. U.S.
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Landscape/Reimbursement Scenario
7.7.2.3. Competitive Insights
7.7.2.4. U.S. Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Canada
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Landscape/Reimbursement Scenario
7.7.3.3. Competitive Insights
7.7.3.4. Canada Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Europe
7.8.1. Europe Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. UK
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Landscape/Reimbursement Scenario
7.8.2.3. Competitive Insights
7.8.2.4. UK Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Germany
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Landscape/Reimbursement Scenario
7.8.3.3. Competitive Insights
7.8.3.4. Germany Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. France
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Landscape/Reimbursement Scenario
7.8.4.3. Competitive Insights
7.8.4.4. France Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Italy
7.8.5.1. Key Country Dynamics
7.8.5.2. Regulatory Landscape/Reimbursement Scenario
7.8.5.3. Competitive Insights
7.8.5.4. Italy Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.6. Spain
7.8.6.1. Key Country Dynamics
7.8.6.2. Regulatory Landscape/Reimbursement Scenario
7.8.6.3. Competitive Insights
7.8.6.4. Spain Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.7. Sweden
7.8.7.1. Key Country Dynamics
7.8.7.2. Regulatory Landscape/Reimbursement Scenario
7.8.7.3. Competitive Insights
7.8.7.4. Sweden Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.8. Denmark
7.8.8.1. Key Country Dynamics
7.8.8.2. Regulatory Landscape/Reimbursement Scenario
7.8.8.3. Competitive Insights
7.8.8.4. Denmark Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.9. Norway
7.8.9.1. Key Country Dynamics
7.8.9.2. Regulatory Landscape/Reimbursement Scenario
7.8.9.3. Competitive Insights
7.8.9.4. Norway Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Asia Pacific
7.9.1. Asia Pacific Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.2. China
7.9.2.1. Key Country Dynamics
7.9.2.2. Regulatory Landscape/Reimbursement Scenario
7.9.2.3. Competitive Insights
7.9.2.4. China Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.3. Japan
7.9.3.1. Key Country Dynamics
7.9.3.2. Regulatory Landscape/Reimbursement Scenario
7.9.3.3. Competitive Insights
7.9.3.4. Japan Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.4. India
7.9.4.1. Key Country Dynamics
7.9.4.2. Regulatory Landscape/Reimbursement Scenario
7.9.4.3. Competitive Insights
7.9.4.4. India Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.5. South Korea
7.9.5.1. Key Country Dynamics
7.9.5.2. Regulatory Landscape/Reimbursement Scenario
7.9.5.3. Competitive Insights
7.9.5.4. South Korea Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.6. Australia
7.9.6.1. Key Country Dynamics
7.9.6.2. Regulatory Landscape/Reimbursement Scenario
7.9.6.3. Competitive Insights
7.9.6.4. Australia Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.7. Thailand
7.9.7.1. Key Country Dynamics
7.9.7.2. Regulatory Landscape/Reimbursement Scenario
7.9.7.3. Competitive Insights
7.9.7.4. Thailand Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Latin America
7.10.1. Latin America Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.2. Brazil
7.10.2.1. Key Country Dynamics
7.10.2.2. Regulatory Landscape/Reimbursement Scenario
7.10.2.3. Competitive Insights
7.10.2.4. Brazil Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.3. Mexico
7.10.3.1. Key Country Dynamics
7.10.3.2. Regulatory Landscape/Reimbursement Scenario
7.10.3.3. Competitive Insights
7.10.3.4. Mexico Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.4. Argentina
7.10.4.1. Key Country Dynamics
7.10.4.2. Regulatory Landscape/Reimbursement Scenario
7.10.4.3. Competitive Insights
7.10.4.4. Argentina Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11. Middle East and Africa
7.11.1. Middle East and Africa Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Key Country Dynamics
7.11.2.2. Regulatory Landscape/Reimbursement Scenario
7.11.2.3. Competitive Insights
7.11.2.4. Saudi Arabia Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.3. UAE
7.11.3.1. Key Country Dynamics
7.11.3.2. Regulatory Landscape/Reimbursement Scenario
7.11.3.3. Competitive Insights
7.11.3.4. UAE Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.4. South Africa
7.11.4.1. Key Country Dynamics
7.11.4.2. Regulatory Landscape/Reimbursement Scenario
7.11.4.3. Competitive Insights
7.11.4.4. South Africa Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.5. Kuwait
7.11.5.1. Key Country Dynamics
7.11.5.2. Regulatory Landscape/Reimbursement Scenario
7.11.5.3. Competitive Insights
7.11.5.4. Kuwait Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Market Share Analysis
8.4. Company Heat Map Analysis
8.5. Strategy Mapping
8.5.1. Expansion
8.5.2. Mergers & Acquisition
8.5.3. Partnerships & Collaborations
8.5.4. New Product Launches
8.5.5. Research And Development
8.6. Company Profiles
8.6.1. Abbott Nutrition
8.6.1.1. Participant’s Overview
8.6.1.2. Financial Performance
8.6.1.3. Product Benchmarking
8.6.1.4. Recent Developments
8.6.2. Pfizer Inc.
8.6.2.1. Participant’s Overview
8.6.2.2. Financial Performance
8.6.2.3. Product Benchmarking
8.6.2.4. Recent Developments
8.6.3. Bayer AG
8.6.3.1. Participant’s Overview
8.6.3.2. Financial Performance
8.6.3.3. Product Benchmarking
8.6.3.4. Recent Developments
8.6.4. Nestle.
8.6.4.1. Participant’s Overview
8.6.4.2. Financial Performance
8.6.4.3. Product Benchmarking
8.6.4.4. Recent Developments
8.6.5. Baxter International Inc.
8.6.5.1. Participant’s Overview
8.6.5.2. Financial Performance
8.6.5.3. Product Benchmarking
8.6.5.4. Recent Developments
8.6.6. Otsuka Holdings Co., Ltd.
8.6.6.1. Participant’s Overview
8.6.6.2. Financial Performance
8.6.6.3. Product Benchmarking
8.6.6.4. Recent Developments
8.6.7. Mead Johnson & Company, LLC
8.6.7.1. Participant’s Overview
8.6.7.2. Financial Performance
8.6.7.3. Product Benchmarking
8.6.7.4. Recent Developments
8.6.8. Danone (Nutricia)
8.6.8.1. Participant’s Overview
8.6.8.2. Financial Performance
8.6.8.3. Product Benchmarking
8.6.8.4. Recent Developments
8.6.9. Victus, Inc.
8.6.9.1. Participant’s Overview
8.6.9.2. Financial Performance
8.6.9.3. Product Benchmarking
8.6.9.4. Recent Developments
8.6.10. Fresenius Kabi
8.6.10.1. Participant’s Overview
8.6.10.2. Financial Performance
8.6.10.3. Product Benchmarking
8.6.10.4. Recent Developments
8.6.11. Meiji Holdings. Co., Ltd.
8.6.11.1. Participant’s Overview
8.6.11.2. Financial Performance
8.6.11.3. Product Benchmarking
8.6.11.4. Recent Developments
8.6.12. AbbVie (Allergan)
8.6.12.1. Participant’s Overview
8.6.12.2. Financial Performance
8.6.12.3. Product Benchmarking
8.6.12.4. Recent Developments
8.6.13. Baxter
8.6.13.1. Participant’s Overview
8.6.13.2. Financial Performance
8.6.13.3. Product Benchmarking
8.6.13.4. Recent Developments
8.6.14. Grifols, S.A.
8.6.14.1. Participant’s Overview
8.6.14.2. Financial Performance
8.6.14.3. Product Benchmarking
8.6.14.4. Recent Developments

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings